Fresenius | FRE - Operating Profit



Fresenius reported EUR560M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Akzo Nobel EUR 303M 111M Jun/2025
Alcon AG USD 247M 221M Jun/2025
AstraZeneca USD 3.51B 166M Jun/2025
BASF EUR 827M 370M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Beiersdorf EUR 816M 370M Jun/2025
DaVita Healthcare Partners USD 530.48M 97.15M Jun/2025
Demant DKK 1.87B 471M Jun/2025
E.ON EUR 1.06B 382M Jun/2025
Essilor EUR 2B 1.22B Jun/2025
Fresenius EUR 560M 127M Jun/2025
Fresenius Medical Care EUR 431M 100M Jun/2025
Getinge SEK 1.08B 900M Dec/2024
Givaudan CHF 364.5M 165.5M Jun/2024
GlaxoSmithKline GBP 2.02B 193M Jun/2025
GN Store Nord DKK 461M 246M Jun/2025
GRIFOLS EUR 349.54M 80.68M Jun/2025
Hikma Pharmaceutical USD 282M 45M Dec/2024
Lonza CHF 430M 104M Dec/2024
Merck EUR 1.03B 24M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Philips EUR 488M 334M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
RWE EUR 637M 119M Jun/2025
Sanofi EUR 1.71B 573M Jun/2025
Smith & Nephew USD 440M 111M Jun/2025